Ignite Creation Date:
2025-12-24 @ 6:28 PM
Ignite Modification Date:
2026-02-24 @ 10:56 AM
Study NCT ID:
NCT02827968
Status:
COMPLETED
Last Update Posted:
2021-06-02
First Post:
2016-06-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 1 Study of Anti-PD-L1 Monoclonal Antibody KN035 to Treat Locally Advanced or Metastatic Solid Tumors
Sponsor:
3D Medicines (Sichuan) Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-01-13
Start Date Type:
ACTUAL
Primary Completion Date:
2020-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-12
Completion Date Type:
ACTUAL
First Submit Date:
2016-06-29
First Submit QC Date:
None
Study First Post Date:
2016-07-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-05-31
Last Update Post Date:
2021-06-02
Last Update Post Date Type:
ACTUAL